Dolby Laboratories Inc
For the period ended Mar 28, 2025. Filed May 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 28, 2025 · Filed May 1, 2025
DLB$64.67-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Interim Condensed Consolidated Statements of Stockholders' Equity
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
| Dolby Laboratories, Inc. | |||||||
|---|---|---|---|---|---|---|---|
| CommonStock | AdditionalPaid-InCapital | RetainedEarnings | AccumulatedOtherComprehensiveIncome/(Loss) | Total Stockholders' Equity - DolbyLaboratories,Inc. | NoncontrollingInterest | Total Stockholders' Equity | |
| Balance as of December 27, 2024 | $95 | $— | $2,543,413 | $(35,542) | $2,507,966 | $9,062 | $2,517,028 |
| Net income | — | — | 91,793 | — | 91,793 | 433 | 92,226 |
| Other comprehensive income, net of tax | — | — | — | 7,564 | 7,564 | 96 | 7,660 |
| Distributions to noncontrolling interest | — | — | — | — | — | (241) | (241) |
| Stock-based compensation expense | — | 30,664 | — | — | 30,664 | — | 30,664 |
| Capitalized stock-based compensation expense | — | 53 | — | — | 53 | — | 53 |
| Repurchase of common stock | (1) | (33,173) | (1,825) | — | (34,999) | — | (34,999) |
| Cash dividends declared and paid on common stock | — | — | (31,829) | — | (31,829) | — | (31,829) |
| Common stock issued under employee stock plans | 1 | 3,966 | — | — | 3,967 | — | 3,967 |
| Tax withholdings on vesting of restricted stock | — | (1,510) | — | — | (1,510) | — | (1,510) |
| Balance as of March 28, 2025 | $95 | $— | $2,601,552 | $(27,978) | $2,573,669 | $9,350 | $2,583,019 |
| Dolby Laboratories, Inc. | |||||||
|---|---|---|---|---|---|---|---|
| CommonStock | AdditionalPaid-InCapital | RetainedEarnings | AccumulatedOtherComprehensiveLoss | Total Stockholders' Equity - DolbyLaboratories,Inc. | NoncontrollingInterest | Total Stockholders' Equity | |
| Balance as of September 27, 2024 | $94 | $— | $2,496,255 | $(19,187) | $2,477,162 | $9,731 | $2,486,893 |
| Net income | — | — | 159,615 | — | 159,615 | 681 | 160,296 |
| Other comprehensive loss, net of tax | — | — | — | (8,791) | (8,791) | (81) | (8,872) |
| Distributions to noncontrolling interest | — | — | — | — | — | (981) | (981) |
| Stock-based compensation expense | — | 66,734 | — | — | 66,734 | — | 66,734 |
| Capitalized stock-based compensation expense | — | 151 | — | — | 151 | — | 151 |
| Repurchase of common stock | (1) | (59,074) | 9,076 | — | (49,999) | — | (49,999) |
| Cash dividends declared and paid on common stock | — | — | (63,377) | — | (63,377) | — | (63,377) |
| Common stock issued under employee stock plans | 2 | 26,122 | — | — | 26,124 | — | 26,124 |
| Tax withholdings on vesting of restricted stock | — | (33,933) | (17) | — | (33,950) | — | (33,950) |
| Balance as of March 28, 2025 | $95 | $— | $2,601,552 | $(27,978) | $2,573,669 | $9,350 | $2,583,019 |
| Dolby Laboratories, Inc. | |||||||
|---|---|---|---|---|---|---|---|
| CommonStock | AdditionalPaid-InCapital | RetainedEarnings | Accumulated Other Comprehensive Loss | Total Stockholders' Equity - DolbyLaboratories,Inc. | NoncontrollingInterest | Total Stockholders' Equity | |
| Balance as of December 29, 2023 | $94 | $— | $2,367,182 | $(21,428) | $2,345,848 | $16,462 | $2,362,310 |
| Net income | — | — | 97,830 | — | 97,830 | 384 | 98,214 |
| Other comprehensive loss, net of tax | — | — | — | (7,640) | (7,640) | (61) | (7,701) |
| Stock-based compensation expense | — | 28,915 | — | — | 28,915 | — | 28,915 |
| Capitalized stock-based compensation expense | — | 110 | — | — | 110 | — | 110 |
| Repurchase of common stock | — | (38,577) | 13,580 | — | (24,997) | — | (24,997) |
| Cash dividends declared and paid on common stock | — | — | (28,716) | — | (28,716) | — | (28,716) |
| Common stock issued under employee stock plans | — | 11,044 | — | — | 11,044 | — | 11,044 |
| Tax withholdings on vesting of restricted stock | — | (1,492) | — | — | (1,492) | — | (1,492) |
| Balance as of March 29, 2024 | $94 | $— | $2,449,876 | $(29,068) | $2,420,902 | $16,785 | $2,437,687 |
| Dolby Laboratories, Inc. | |||||||
|---|---|---|---|---|---|---|---|
| CommonStock | AdditionalPaid-InCapital | RetainedEarnings | Accumulated Other Comprehensive Income/(Loss) | Total Stockholders' Equity - DolbyLaboratories,Inc. | NoncontrollingInterest | Total Stockholders' Equity | |
| Balance as of September 29, 2023 | $94 | $— | $2,391,990 | $(36,984) | $2,355,100 | $17,084 | $2,372,184 |
| Net income | — | — | 164,811 | — | 164,811 | 984 | 165,795 |
| Other comprehensive income, net of tax | — | — | — | 7,916 | 7,916 | 79 | 7,995 |
| Distributions to noncontrolling interest | — | — | — | — | — | (1,047) | (1,047) |
| Stock-based compensation expense | — | 60,809 | — | — | 60,809 | — | 60,809 |
| Capitalized stock-based compensation expense | — | 205 | — | — | 205 | — | 205 |
| Repurchase of common stock | (1) | (54,664) | (50,334) | — | (104,999) | — | (104,999) |
| Cash dividends declared and paid on common stock | — | — | (57,268) | — | (57,268) | — | (57,268) |
| Common stock issued under employee stock plans | 1 | 29,344 | — | — | 29,345 | — | 29,345 |
| Tax withholdings on vesting of restricted stock | — | (36,054) | — | — | (36,054) | — | (36,054) |
| Deconsolidation of subsidiary | — | — | 677 | — | 677 | (677) | — |
| Equity issued in connection with business combination | — | 360 | — | — | 360 | 362 | 722 |
| Balance as of March 29, 2024 | $94 | $— | $2,449,876 | $(29,068) | $2,420,902 | $16,785 | $2,437,687 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.